
               
               
               7 DRUG INTERACTIONS
               
                  No significant drug-drug interactions are anticipated between ZERBAXA and substrates, inhibitors, and inducers of cytochrome P450 enzymes (CYPs) [see Clinical Pharmacology (12.3)].
               
               
            
         